Fig. 6From: Circulating NPTX2 methylation as a non-invasive biomarker for prognosis and monitoring of metastatic pancreatic cancerCirculating NPTX2 methylation correlates with patient’s outcome and survival. Correlation analyses showed a significant inverse relationship between survival and circulating NPTX2 methylation levels (A). But not with circulating CA19-9 levels (B)Back to article page